The Archive
Everything we've published
415 articles across your industry — the developments, rule changes, and moves that touch your business. Browse by section, or search for what you need.
- Evolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance Aug 9, 2026
- Hugel Posts Record H1 Earnings on Toxin Growth Aug 8, 2026
- AbbVie Files Material Event—Allē Rebate Terms Shifting Aug 7, 2026
- Evolus Files Material Event—Jeuveau Pricing Escalates Aug 7, 2026
- Evolus Posts Third Straight Profitable Quarter, Raises Outlook Aug 6, 2026
- Evolus Files Material Event—Jeuveau Pricing Shift Ahead Aug 5, 2026
- Galderma Raises 2026 Guidance After $3.1B H1 Sales Aug 4, 2026
- Steel Partners Escalates InMode Pressure Over Governance Aug 2, 2026
- Berenberg Backs Galderma's Integrated Model After H1 Beat Aug 1, 2026
- RBC Lifts Galderma Outlook Following H1 Beat Aug 1, 2026
- AbbVie Files Material Event—Botox/Juvéderm Pricing Shift Ahead Jul 31, 2026
- Hugel Aesthetics Launches Direct Sales Force for Letybo, Expands US Footprint Jul 29, 2026
- Galderma Posts $3.1B H1 Sales, Raises 2026 Outlook Jul 28, 2026
- Hugel Aesthetics Builds U.S. Direct Sales Force for Letybo and K-TOX Campaign Jul 28, 2026
- Hugel Launches Letybo in India, Expanding Asia-Pacific Footprint Jul 25, 2026
- Hugel Aesthetics Builds U.S. Footprint with Direct Sales Force for Letybo and K-TOX Campaign Jul 25, 2026
- Hugel Aesthetics Builds Direct Sales Force for Letybo and K-TOX in U.S. Market Jul 24, 2026
- Galderma Posts Record H1 2026 Sales of $3.1B, Raises Full-Year Guidance Jul 24, 2026
- Steel Partners Offers $16.75 Per Share for InMode—Device Consolidation Accelerates Jul 23, 2026
- Hugel Expands US Footprint With Direct Sales Force for Letybo and New K-TOX Campaign Jul 22, 2026
- Steel Partners Offers to Acquire InMode at $16.75 Per Share; Board Evaluates Rival Bids Jul 22, 2026
- InMode Reports Q2 Revenue $95.2–$95.4M — Steady Growth Amid Acquisition Uncertainty Jul 21, 2026
- Galderma Launches Alastin in Japan, Asia-Pacific Markets Jul 21, 2026
- Steel Partners Bids $16.75 Per Share for InMode — What a Takeover Means for Device Buyers Jul 20, 2026
- InMode Guides Q2 2026 Revenue to $95.2M–$95.4M, Reiterates $365M–$375M Full-Year Target Jul 17, 2026
- Court Bid Filed to Pause InMode Takeover Review — Shareholder Litigation Clouds Steel Partners Offer Jul 16, 2026
- Steel Partners Bids $16.75/Share for InMode — What a Takeout Means for Device Economics Jul 16, 2026
- L'Oréal Raises Galderma Stake to 20%, Deepening Strategic Investment Jul 15, 2026
- InMode Guides Q2 Revenue to $95.2M–$95.4M, Reiterates $365M–$375M FY 2026 Target Jul 15, 2026
- Steel Partners Bids $16.75/Share for InMode — Challenging CEO Buyout Jul 15, 2026
- Steel Partners Bids $16.75/Share for InMode — What a Hostile Takeover Means for Device Buyers Jul 14, 2026
- L'Oréal Raises Galderma Stake to 20% — What Luxury-Goods Capital Means for Aesthetic Pricing Jul 14, 2026
- Sisram Medical Restructures DAXXIFY China Deal With Fosun — Supply Chain Shift Signals Market Consolidation Jul 14, 2026
- L'Oréal Raises Galderma Stake to 20% — Strategic Beauty-Pharma Convergence Play Jul 13, 2026
- Sisram Medical Restructures DAXXIFY China Deal With Fosun — Botulinum Toxin Strategy Shifts Jul 13, 2026
- Steel Partners Offers $16.75/Share for InMode — Rival Bid Challenges CEO Buyout Jul 13, 2026
- L'Oréal Boosts Galderma Stake to 20% — Strategic Consolidation in Aesthetics Jul 12, 2026
- Sisram Medical Restructures DAXXIFY China Deal With Fosun Unit — Supply Chain Complexity Deepens Jul 12, 2026
- Steel Partners Bids $16.75/Share for InMode — What a Contested Takeover Means for Device Buyers Jul 11, 2026
- AbbVie Allergan Aesthetics Files Material Event — Botox and Juvéderm Pricing or Loyalty Changes Likely Jul 11, 2026
- Evolus Files Material Event on Jeuveau Loyalty Program — Pricing and Rebate Moves Signal Market Pressure Jul 11, 2026
- Steel Partners Bids $16.75 Per Share for InMode — Unsolicited Offer Challenges CEO Buyout Jul 10, 2026
- InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Device Market Jul 8, 2026
- AbbVie Files Material 8-K on Allergan Aesthetics — Pricing or Rebate Shift Likely Ahead Jul 7, 2026
- L'Oréal Boosts Galderma Stake to 20% — Strategic Bet on Aesthetics and Skincare Convergence Jul 7, 2026
- InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Energy-Device Space Jul 7, 2026
- AbbVie Files Material Event on Allergan Aesthetics — Pricing or Rebate Move Likely Incoming Jul 7, 2026
- InMode Confirms Receipt of Unsolicited Takeover Proposal — Strategic Interest Signals Market Consolidation Jul 6, 2026
- InMode Receives Unsolicited Buyout Proposal at $16.20 per Share — M&A Signals Consolidation Pressure Jul 6, 2026
- Evolus Files Material Events — Jeuveau Pricing and Evolus Rewards Program Under Strategic Review Jul 3, 2026
- AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing and Rebate Moves Signal Margin Pressure Jul 3, 2026
- L'Oréal Increases Stake in Galderma to 20% — Consolidation Pressure Mounts in Aesthetics Jul 3, 2026
- AbbVie Allergan Aesthetics Files Multiple Material Events — Botox/Juvéderm Pricing or Allē Loyalty Shifts Imminent Jul 2, 2026
- L'Oréal Boosts Galderma Stake to 20% — Strategic Consolidation in Premium Filler Market Jul 2, 2026
- Evolus Files Material Event — Jeuveau Pricing or Loyalty Program Shift Likely Jul 2, 2026
- AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing or Rebate Adjustments Likely Jul 1, 2026
- Evolus Files Material Event: Jeuveau Loyalty Program Signals Aggressive Medspa Push Jun 30, 2026
- AbbVie Files Multiple Material Events — Botox/Juvéderm Pricing or Rebate Moves Imminent Jun 30, 2026
- Allergan Aesthetics Files Multiple Material Events: Pricing and Rebate Moves Signal Margin Pressure Jun 29, 2026
- Evolus Files Multiple Material Events — Jeuveau Pricing Strategy Intensifies Jun 29, 2026
- AbbVie Files Multiple Material Events — Allergan Aesthetics Pricing and Rebate Moves Signal Margin Pressure Across Injectable Market Jun 28, 2026
- Evolus Files Multiple Material Events — Jeuveau Pricing and Loyalty Program Moves Target Medspa Market Share Jun 28, 2026
- AbbVie's Allergan Aesthetics Files Multiple Material Events — Pricing and Rebate Moves Ahead Jun 27, 2026
- Evolus Files Multiple Material Events — Jeuveau Competitive Moves Underway Jun 27, 2026
- Evolus Files Multiple Material Events — Jeuveau Competitive Pricing Strategy in Motion Jun 27, 2026
- AbbVie Files Multiple Material Events — Allergan Aesthetics Pricing or Rebate Moves Likely Ahead Jun 27, 2026
- Medspa Franchise vs Independent Practice: Cost, Control, and Unit Economics Jun 26, 2026
- Should Your Medspa Have a Membership Program? Models, Metrics, and Revenue Impact Jun 26, 2026
- How to Market a Medspa: High-Converting Channels and Real Unit Economics Jun 26, 2026
- How Much Revenue Can One MedSpa Treatment Room Generate? Jun 26, 2026
- How Much Does It Cost to Open a Medspa? Real Buildout, Device, and Staffing Numbers Jun 26, 2026
- Boulevard vs Aesthetic Record vs PatientNow: Which Medspa Software Fits Your Practice Jun 26, 2026
- What It Takes to Open a Medical Spa: Licensing, Medical Director, Ownership, and Capital Requirements Jun 26, 2026
- How to Price Lip Filler at Your MedSpa: Cost Inputs, Market Rates, and Packaging Strategy Jun 26, 2026
- Medspa Profit Margins: What's Normal by Service Line Jun 26, 2026
- Botox Cost Per Unit and Profit Margin: The Real Economics for Medspa Owners Jun 26, 2026
- InMode Receives Unsolicited $16.20-Per-Share Acquisition Proposal — Device Consolidation Accelerates Jun 26, 2026
- Med Spa Valuation and Exit Basics: What Makes a Practice Worth Buying Jun 6, 2026
- InMode Q2 Beats EPS Forecast, Revenue Tops Estimates Aug 9, 2026
- InMode Q2 Revenue Beats Estimates at $95.6M Aug 8, 2026
- Sofwave Q2 Revenue Accelerates on Ultrasonic Demand Aug 8, 2026
- InMode Q2 Revenue Beats on Steady U.S. Device Demand Aug 7, 2026
- InMode Q2 Beats on Steady U.S. Device Demand Aug 6, 2026
- Sofwave Q2 Revenue Accelerates on Ultrasonic Demand Aug 6, 2026
- Sofwave Q2 Revenue Jumps 43% YoY to $30M Aug 5, 2026
- InMode Q2 Flat Revenue, Margins Compress Aug 5, 2026
- RF Microneedling Adverse Events Draw Clinical Review Aug 4, 2026
- Indonesia Opens Botulinum Toxin Plant—2028 Production Aug 3, 2026
- SkinStylus Gets FDA Nod for Periorbital Wrinkles Aug 2, 2026
- Alma Lasers Launches Harmony Platform in India—Multi-Modality Push Jul 31, 2026
- Aesthetic Lasers Market Projected to Hit $11.1B by 2036 Jul 30, 2026
- Alma Lasers Launches Harmony Platform in India, Signals Multi-Modality Strategy Jul 29, 2026
- Galderma Rolls Out Alastin Regenerative Skincare Across JPAC Region Jul 20, 2026
- Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Enters Market Jul 20, 2026
- Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Competes with Thermage Jul 16, 2026
- Cynosure Lutronic Launches XERF Monopolar RF Platform in Europe Jul 16, 2026
- Cynosure Lutronic Launches Next-Generation Monopolar RF in Europe — Non-Invasive Skin Tightening Demand Accelerates Jul 13, 2026
- Cynosure Lutronic's XERF Accelerates Adoption as Leading Monopolar RF Platform — Competitive Pressure on InMode Jul 12, 2026
- Hugel's Botulinum Toxin Manufacturing Scales to 25,000 Vials From Thumb-Sized Tube — Supply Dynamics Shift Jul 12, 2026
- Hugel's Toxin Manufacturing Scales to 25,000 Vials From a Thumb-Sized Tube — Supply Chain Efficiency Jul 12, 2026
- SkinStylus Receives FDA Clearance for Periorbital Wrinkles Across All Skin Types Jul 11, 2026
- Cynosure Lutronic's XERF Gains Traction as Monopolar RF Leader — Market Share Shift in Body Contouring Jul 11, 2026
- Fotona Reports Surge in Younger Patient Bookings for 'Collagen Banking' — Preventive Laser Trend Gains Traction Jul 11, 2026
- Cynosure Lutronic's XERF Monopolar RF Platform Gains Rapid Adoption Across North America Jul 11, 2026
- Fractional RF Microneedle Market Valued at $2.3B — Device Consolidation Accelerates Jul 7, 2026
- Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Trend Reshapes Device Mix Jul 7, 2026
- Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Trend Reshapes Device Mix Jul 7, 2026
- Sisram Medical Launches China Manufacturing for Alma Rejuve — Localized Production Begins Jul 6, 2026
- Sisram Medical Launches China Manufacturing for Alma Rejuve — Supply Chain Shift Underway Jul 6, 2026
- Queen City Dermatology Becomes First Cincinnati Practice to Offer XERF Radiofrequency Jul 4, 2026
- Cynosure's XERF Radiofrequency Now 3x Faster — Adoption Accelerates Across Clinics Jul 4, 2026
- XERF Radiofrequency Adoption Accelerates — Cynosure Lutronic's Speed Advantage Reshapes Device Economics Jun 29, 2026
- Cynosure Lutronic's XERF Radiofrequency System Sees Accelerating Adoption — Now 3x Faster Processing Speed Jun 28, 2026
- Cynosure Lutronic's XERF Radiofrequency Now 3x Faster — Device Economics Shift Jun 27, 2026
- XERF Radiofrequency Adoption Accelerates — Cynosure Lutronic Reports 3x Speed Improvement Jun 27, 2026
- Aesthetic Laser Costs: Price Ranges by Modality and Break-Even Economics Jun 26, 2026
- CoolSculpting vs Emsculpt vs truSculpt vs SculpSure: Body-Contouring ROI for Medspa Owners Jun 26, 2026
- HydraFacial vs. Regular Facial: Clinical Mechanism, Economics, and Menu Positioning for Medspa Owners Jun 26, 2026
- Microneedling vs RF Microneedling: Clinical Depth, Energy Delivery, Results, and Device ROI for Practice Owners Jun 26, 2026
- Exosomes in Aesthetics: What the Science Shows and Why the FDA Hasn't Approved Them Jun 26, 2026
- Ellacor: How Candela's Micro-Coring Technology Works and What FDA Approval Means for Your Practice Jun 26, 2026
- Emsculpt NEO: HIFEM + RF Body Contouring for Medspa Owners Jun 26, 2026
- Emface: How BTL's Needle-Free HIFES + RF Lift Works and What It Means for Your Practice Jun 26, 2026
- Morpheus8 Machine Cost: Acquisition, Consumables, and Break-Even Patient Volume Jun 26, 2026
- What Is Sofwave? How Ultrasound Microthermal Therapy Works for Skin Tightening Jun 26, 2026
- PDO Thread Lifts: How They Work, Results, Longevity, and Risk Profile Jun 26, 2026
- PRP vs PRF in Aesthetics: Preparation, Clinical Uses, and Evidence Jun 26, 2026
- RF Microneedling: How It Works, Clinical Indications, and Leading Devices Jun 26, 2026
- What Is Morpheus8? RF Microneedling Technology, Clinical Applications, and Practice Economics Jun 26, 2026
- Ultherapy vs Sofwave: Comparing Ultrasound and Radiofrequency Skin Tightening Jun 26, 2026
- CoolSculpting vs Emsculpt: Mechanisms, Results, and Practice Economics Jun 26, 2026
- Morpheus8 vs. Vivace: RF Microneedling Depth, Results, and Practice ROI Compared Jun 26, 2026
- The Used / Gray-Market Device Question: Service Lockouts, Liability, and When It's a Trap Jun 24, 2026
- The Body Contouring Buy Decision: Cryolipolysis vs RF vs HIFU vs Muscle-Stim on Demand and Repeat Rate Jun 21, 2026
- Warranty and Service-Contract Negotiation: The Clauses That Cost You Later Jun 19, 2026
- Device ROI Models That Actually Hold Up: Treating $/Pulse, Consumables, and Downtime as Real Costs Jun 15, 2026
- Reading a Device Clinical Claim: '510(k) Cleared For' vs What the Rep Is Implying It Does Jun 13, 2026
- Lease vs Finance vs Buy on a $120K Platform: The Tax and Cash-Flow Math Reps Won't Show You Jun 10, 2026
- What Is a 'Vampire Facial'? The PRP Treatment Behind the Name, for Owners Jun 9, 2026
- Chemical Peel vs Microdermabrasion: Matching Exfoliation Intensity to the Patient Jun 8, 2026
- IPL vs BBL: Understanding the Light-Based Options Patients Ask About Jun 8, 2026
- Microneedling vs Laser Resurfacing: Two Routes to Skin Renewal, Different Intensity and Cost Jun 7, 2026
- What Is Microchanneling? Understanding a Microneedling-Adjacent Treatment Jun 7, 2026
- The Consumables Trap: Why 'Cheap' Energy Devices With Per-Tip Costs Beat You on Margin Jun 7, 2026
- Muscle vs Fat Body Contouring: Comparing Energy-Based Approaches for Owners Jun 6, 2026
- HydraFacial vs Dermaplaning: Two Popular 'Glow' Treatments Compared Jun 5, 2026
- How Much Does CoolSculpting Cost — and Does the Device Math Work for Your Practice? Jun 5, 2026
- CoolSculpting vs Liposuction: Non-Invasive Device vs Surgical Fat Removal Jun 4, 2026
- How Much Does Microneedling Cost — and How Owners Should Price the Series Jun 4, 2026
- How Many Microneedling Sessions — Framing the Series for Results and Revenue Jun 4, 2026
- Laser vs IPL for Pigmentation: Choosing the Right Light for the Concern Jun 4, 2026
- Chemical Peel vs Laser Resurfacing: Matching the Treatment to the Patient and the Downtime Jun 4, 2026
- Microneedling vs Chemical Peel: Two Routes to Better Skin Texture Jun 3, 2026
- PRP vs Microneedling: How They Differ and Why They're Often Done Together Jun 3, 2026
- Laser Hair Removal vs Electrolysis: Two Approaches to Hair Reduction Jun 2, 2026
- PRP for Hair Restoration: An Owner's Overview of a Growing Service Line Jun 2, 2026
- FDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear Aug 9, 2026
- AbbVie Wins FDA Review for BOTOX Jawline Indication Aug 7, 2026
- FDA Accepts sBLA for Botox in Masseter Prominence Aug 6, 2026
- AbbVie Wins FDA Review for BOTOX Jawline Indication Aug 5, 2026
- Indiana Tightens Medical Spa Regulations Under Public Law 136 Jul 29, 2026
- SKINVIVE by JUVÉDERM Gains FDA Approval for Neck Lines—New Indication Expands Filler Market Jul 27, 2026
- AbbVie Sues Galderma Over Patented Dermal Filler Syringe Designs Jul 25, 2026
- AbbVie Wins EU Approval for Boey, Its Rapid-Onset Botulinum Toxin Jul 24, 2026
- AbbVie Wins EU Approval for Boey, Its Short-Acting Botulinum Toxin Jul 22, 2026
- Medicare Begins Price Negotiation on Botox and 14 Other Drugs — Regulatory Headwind for Toxin Economics Jul 18, 2026
- Medicare Begins Price Negotiation for Botox and 14 Other Drugs — Reimbursement Pressure Ahead Jul 16, 2026
- Medicare Adds Botox to Price-Negotiation List — What Payers Negotiating Toxin Costs Means for Your Reimbursement Jul 15, 2026
- Galderma Provides Update on Relabotulinum BLA — Third Toxin Competitor Advances Toward FDA Approval Jul 12, 2026
- Galderma Updates Relabotulinum BLA Status With FDA — Third Neuromodulator Nears U.S. Approval Jul 11, 2026
- Galderma Provides Update on RelabotulinumtoxinA BLA Review — Third Botulinum Toxin Competitor Advances Jul 11, 2026
- Galderma's Relfydess Botox Rival Hits FDA Roadblock — What Practices Need to Know Jul 7, 2026
- Galderma Gets Complete Response Letter on RelabotulinumtoxinA — What Went Wrong Jul 5, 2026
- Galderma Receives Complete Response Letter for Relfydess — Botox Rival Faces Regulatory Hurdle Jul 4, 2026
- Daewoong's NABOTA Enters Seventh Middle East Market Aug 9, 2026
- Daewoong's Nabota Completes 7-Market GCC Sweep Aug 4, 2026
- GLP-1 Weight Loss Boom Lifts Galderma Aesthetics Sales 25% Jul 31, 2026
- Daewoong's Nabota Enters Kuwait—Completes 7-Market GCC Sweep Jul 31, 2026
- Daewoong's Nabota Enters Kuwait—7th Middle East Market Jul 30, 2026
- Galderma Capitalizes on GLP-1 Weight-Loss Trend—What Practices Need to Know Jul 27, 2026
- Daewoong's Nabota Hits 1 Trillion Won in Cumulative Sales—Asian Toxin Market Matures Jul 27, 2026
- "Ozempic Face" Facials Driving Botox Boom as GLP-1 Users Seek Preventive Aesthetics Jul 27, 2026
- Galderma Capitalizes on GLP-1 Weight Loss Trend—What Practices Should Know Jul 26, 2026
- Daewoong's Nabota Crosses 1 Trillion Won in Cumulative Sales—Asian Toxin Gains Scale Jul 26, 2026
- "Ozempic Face" Facials Driving Botox Boom—Practices Capitalize on GLP-1 Side Effect Jul 26, 2026
- Galderma Capitalizes on GLP-1 Weight Loss Trend; 'Ozempic Face' Drives Filler and Toxin Demand Jul 25, 2026
- Hugel Launches Letybo in India — Expanding Asia-Pacific Footprint Jul 24, 2026
- Hugel Launches Letybo in India, Targets 9% Market Share by 2026 Jul 23, 2026
- Galderma Raises Full-Year Guidance After Record First-Half Sales of $3.13B Jul 23, 2026
- Hugel Launches Letybo in India, Targets 9% Market Share by 2026 Jul 22, 2026
- GLP-1 Aesthetic Care Market Projected to Reach $2B by 2030 — New Revenue Stream for Medspa Operators Jul 19, 2026
- InMode Guides Q2 Revenue to $95.2M–$95.4M — Growth Resilience Amid Takeover Uncertainty Jul 18, 2026
- InMode Projects Q2 Revenue $95.2M–$95.4M, Reiterates $365M–$375M FY 2026 Guidance Jul 16, 2026
- GLP-1 Aesthetic Care Market Projected to Hit $2B by 2030 — New Revenue Stream or Threat? Jul 16, 2026
- Daewoong's Nabota Hits 1 Trillion Won in Sales — Korean Toxin Maker Accelerates U.S. and Global Expansion Jul 14, 2026
- GLP-1 Weight-Loss Boom Drives Post-Bariatric Body Contouring Surge — New Patient Pipeline for Medspas Jul 13, 2026
- InMode Guides Q2 2026 Revenue to $95.2M–$95.4M; Full-Year Outlook Holds at $365M–$375M Jul 13, 2026
- GLP-1 Weight-Loss Boom Drives Post-Reduction Body Contouring at Medspa Practices — New Revenue Stream Emerging Jul 12, 2026
- GLP-1 Weight-Loss Boom Fuels Body-Contouring Volume — Practices Report Surge in Post-Weight-Loss Procedures Jul 12, 2026
- GLP-1 Weight Loss Boom Drives Post-Loss Body Contouring Demand at Aesthetic Practices Jul 11, 2026
- Fotona4D Reports Surge in Younger Patient Bookings — 'Collagen Banking' Becomes 2026 Trend Jul 4, 2026
- Semaglutide Pricing at Medspas: Compounded vs. Branded and What Patients Actually Pay Jun 26, 2026
- Semaglutide Face: Why Medspa Owners Should Offer Fillers to GLP-1 Patients Jun 26, 2026
- Offering GLP-1 Weight Loss at a Medspa: Sourcing, Compliance, and Revenue Model Jun 26, 2026
- GLP-1 Weight Loss Boom Drives 'Semaglutide Face' — Aesthetic Practices Report Surge in Volume Restoration Demand Jun 26, 2026
- Evolus Rewards Program Terms Changed—Review Now Aug 8, 2026
- Daewoong Tightens Nabota Distribution After Gray-Market Leak Aug 2, 2026
- Alert: SkinMedica/Allergan Brand Terms Page Updated — Review Your Loyalty Program Now Jul 7, 2026
- SkinMedica/Allergan Program Terms Shifted — Verify Rebate and Loyalty Thresholds Now Jul 7, 2026
- Can a Medspa Prescribe Semaglutide? Scope, Regulations, and State Variation Jun 26, 2026
- How to Find and Hire a Medical Director for Your Medspa Jun 26, 2026
- Do You Need to Be a Doctor to Own a Medspa? Ownership Rules and MSO Structures Jun 26, 2026
- Can a Nurse Practitioner Own a Medical Spa? State Rules, CPOM, and MSO Structures Jun 26, 2026
- Is Compounded Semaglutide Legal for Medspas? FDA Status, Compounding Rules, and Enforcement Risk Jun 26, 2026
- Medical Director Requirements for Medspas: Role, Supervision, and Liability Jun 26, 2026
- Can an RN Inject Botox Without a Doctor? State Scope-of-Practice Rules and Supervision Requirements Jun 26, 2026
- Good Faith Exam Requirements for Medical Spas: What Owners Need to Know Jun 26, 2026
- Non-Compete and Non-Solicit for Injectors: What's Enforceable After the FTC Rule Shakeout Jun 21, 2026
- Med Spa Advertising Law: The FTC and State-Board Rules on 'Results,' Testimonials, and Influencer Posts Jun 21, 2026
- The Patient Intake and Contraindication Reference: Screening That Prevents the Lawsuit Jun 20, 2026
- OSHA in an Aesthetic Practice: The Bloodborne-Pathogen and Hazard Citations Owners Miss Jun 18, 2026
- Handling an Adverse Event: The Documentation, Reporting, and Board-Complaint Survival Guide Jun 18, 2026
- Corporate Practice of Medicine, Decoded: Why Your Ownership Structure May Be Illegal in Your State Jun 17, 2026
- IV Therapy's Regulatory Gray Zone: Compounding, Standing Orders, and the New Scrutiny Jun 16, 2026
- HIPAA for Medspas: The Before/After Photo, Texting, and Social-Media Consent Failures That Get Fined Jun 15, 2026
- Injectable Storage, Handling, and Cold-Chain Requirements: The Compliance Checklist Jun 14, 2026
- Delegation and Incident-To: Who Can Legally Inject in Your State, and the Supervision Tiers Jun 12, 2026
- Medical Waste and Sharps Disposal: The Compliance Basic That's Easy to Get Wrong Jun 9, 2026
- The 'Tox Party' Compliance Trap: Why Group Events Trigger Good-Faith-Exam and Supervision Problems Jun 9, 2026
- Medical Director on Paper vs in Practice: What 'Supervision' Actually Requires in a CPOM State Jun 9, 2026
- Emergency Protocols: Being Ready for the Rare, Serious Event Jun 8, 2026
- Telehealth in Aesthetics: Where Remote Evaluation Fits and Where It Doesn't Jun 7, 2026
- Chart and Documentation Standards: The Records That Protect You When It Matters Jun 6, 2026
- Good-Faith Exam Done Right: Building a Defensible Workflow With Telehealth and Standing Orders Jun 6, 2026
- The MSO / Management-Services Model: How It's Used, Where It Breaks, and What Regulators Look For Jun 6, 2026
- AbbVie Launches Boey, Rapid-Onset Toxin, in Europe Aug 4, 2026
- JUVÉDERM Day Returns August 19—Promo Details Aug 3, 2026
- SKINVIVE Neck-Line Indication Expands Filler Market Aug 3, 2026
- Galderma Launches Sculptra in India—Regenerative Expansion Aug 3, 2026
- AbbVie Q2 2026: Aesthetics Growth Outpaces Pharma Aug 2, 2026
- Evolus Q2 2023: Revenue Breakdown Signals Jeuveau Stabilization Jul 30, 2026
- Daewoong's Nabota Reaches 1 Trillion Won in Cumulative Sales, Signals Korean Toxin Momentum Jul 29, 2026
- AbbVie Launches Boey, Rapid-Onset Botulinum Toxin, With EU Approval Jul 28, 2026
- Xeomin Enters Neurotoxin Resistance Conversation as Clinical Data Accumulates Jul 28, 2026
- Hugel Builds US Direct Sales Force for Letybo, Launches K-TOX Campaign Jul 23, 2026
- Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neuromodulator Jul 21, 2026
- AbbVie's Boey Wins EU Approval for Frown Lines — First Rapid-Onset Botox Alternative Jul 20, 2026
- Daewoong Pharma's Nabota Surpasses 1 Trillion Won in Sales — South Korean Toxin Accelerates Global Expansion Jul 19, 2026
- Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neuromodulator Jul 19, 2026
- Allergan Aesthetics Wins EU Approval for Boey — First Rapid-Onset, Short-Duration Neurotoxin Reshapes Toxin Economics Jul 18, 2026
- Evolus Expands Jeuveau Rewards Program — Aggressive Pricing War Targets Medspa Market Share Jul 17, 2026
- Evolus Aggressively Markets Jeuveau Through Rewards Program — Neuromodulator Price Wars Intensify Jul 16, 2026
- Daewoong Pharma's Nabota Exceeds 1 Trillion Won in Sales, Accelerates Global Push Jul 15, 2026
- Evolus Ramps Jeuveau Marketing to Medspas via Evolus Rewards Program Jul 15, 2026
- Evolus Aggressively Markets Jeuveau to Medspas via Rewards Program — Price War Signals Intensify Jul 14, 2026
- AbbVie Allergan Files Material Event — Botox/Juvéderm Pricing or Rebate Shift Likely Imminent Jul 14, 2026
- Evolus Secures Exclusive U.S. License for Profhilo — 15-Year Term, No Upfront Fee Jul 13, 2026
- Evolus Secures Exclusive U.S. Profhilo License From IBSA — Skin Quality Injectable Now in Play Jul 12, 2026
- Evolus Secures Exclusive U.S. Profhilo License From IBSA — A Skin-Quality Play to Challenge Juvéderm Jul 11, 2026
- Evolus Secures Exclusive U.S. Rights to Profhilo From IBSA — 15-Year Term, No Upfront Fee Jul 10, 2026
- Allergan Wins FDA Nod for SKINVIVE by JUVÉDERM for Neck — New Indication, Familiar Economics Jul 7, 2026
- Allergan Aesthetics Wins FDA Approval for SKINVIVE by JUVÉDERM for Neck — First Indication Expansion Jul 6, 2026
- AbbVie Wins FDA Approval for SKINVIVE by JUVÉDERM for Neck — First Filler Indication in Category Jul 4, 2026
- FDA Approves Restylane Contour for Temple Hollowing — Galderma Expands Filler Indication Portfolio Jul 3, 2026
- FDA Approves Skinvive by Juvéderm for Neck Appearance — AbbVie Expands Filler Portfolio Beyond Face Jul 3, 2026
- Galderma Wins FDA Approval for Restylane Contour — Temple Indication Expands Structural Filler Segment Jul 2, 2026
- Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Indication Expands Filler Portfolio Jul 2, 2026
- AbbVie Wins FDA Approval for Skinvive by Juvéderm — Neck Indication Expands Filler Portfolio Jul 1, 2026
- Galderma Wins FDA Approval for Restylane Contour — Temple Hollowing Indication Expands Filler Anatomy Jul 1, 2026
- Galderma Wins FDA Clearance for Restylane Contour — Temple Hollowing Now Indicated Jun 30, 2026
- Restylane Contour Approved for Temple Hollowing — Galderma Fills a Clinical Gap Jun 29, 2026
- RHA Dynamic Volume Cleared for Midface Augmentation — Revance Expands Dynamic Filler Footprint Jun 29, 2026
- FDA Approves Skinvive by Juvéderm for Neck Lines — New Indication Expands Allergan's Dermal Filler Portfolio Jun 28, 2026
- Galderma's Restylane Contour Cleared for Temple Hollowing — New Indication, Familiar Filler Jun 28, 2026
- Skinvive by Juvéderm Wins FDA Approval for Neck — What's in Your Filler Mix Now Jun 27, 2026
- Supply-Disruption Early Warning: Reading 483s and Recalls to Stock Ahead of a Shortage Jun 27, 2026
- FDA Clears RHA Dynamic Volume for Midface Augmentation — Revance's Dynamic Filler Gains Broader Indication Jun 27, 2026
- Galderma Wins FDA Clearance for Restylane Contour in Temple Hollowing — Narrower Indication, Broader Competitive Pressure Jun 27, 2026
- FDA Approves Skinvive by Juvéderm for Neck Appearance — What the Indication Means for Your Juvéderm Mix Jun 27, 2026
- How Hyaluronidase Dissolves Filler: Mechanism, Vascular Occlusion Protocol, and Practice Liability Jun 26, 2026
- Botox Units Per Area: Standard Dosing and Practice Economics Jun 26, 2026
- RHA vs Juvéderm: Resilient HA and Vycross Technology Compared for Aesthetic Practice Jun 26, 2026
- Daxxify vs Jeuveau: Duration, Cost, and Clinical Positioning Jun 26, 2026
- Botox vs Xeomin: Which Neuromodulator to Stock and Offer Your Patients Jun 26, 2026
- What Is a Liquid Facelift? Filler and Toxin Combination Strategy for Medspa Owners Jun 26, 2026
- What Is a Skin Booster? Category, Players, FDA Status, and Menu Strategy Jun 26, 2026
- Skinvive by Juvéderm: The Microdroplet HA Skin Booster for Cheek Hydration Jun 26, 2026
- What Is Rejuran? The Polynucleotide Skin Booster Reshaping the Aesthetic Market Jun 26, 2026
- Letybo vs. Botox: Key Differences in Units, Onset, and Clinical Profile for Medspa Owners Jun 26, 2026
- Is Relfydess FDA Approved? Status, Mechanism, and How It Compares to Dysport Jun 26, 2026
- Is Evolysse FDA Approved? Evolus's HA Filler Line Explained Jun 26, 2026
- Sculptra vs Radiesse: Mechanism, Timeline, and Clinical Use Cases for Medspa Owners Jun 26, 2026
- Juvéderm vs Restylane: HA Filler Families Compared by Crosslinking, Indication, and Longevity Jun 26, 2026
- Daxxify vs Botox: Duration, Cost, and When to Use Each Jun 26, 2026
- Botox vs Jeuveau: Which Neuromodulator to Stock and Offer Jun 26, 2026
- Botox vs Dysport: Clinical Differences, Dosing, and Economics for Injectors Jun 26, 2026
- Is Kybella FDA Approved? Current Status and What Medspa Owners Need to Know Jun 26, 2026
- Is Sculptra FDA Approved? Status, Indications, and Clinical Use Jun 26, 2026
- Are RHA Fillers FDA Approved? Current Status and Clinical Use Jun 26, 2026
- Is Xeomin FDA Approved? Status, Indications, and Clinical Profile Jun 26, 2026
- Is Skinvive by Juvéderm FDA Approved? Status, Indications, and Microdroplet Technology Jun 26, 2026
- Is Letybo FDA Approved? Status, Mechanism, and Clinical Position Jun 26, 2026
- Is Jeuveau FDA Approved? Current Status and Clinical Indications Jun 26, 2026
- Is Daxxify FDA Approved? Status, Indications, and How It Compares to Botox Jun 26, 2026
- Allergan Aesthetics Wins FDA Approval for Skinvive by Juvéderm — Neck Wrinkles Now Cleared Jun 26, 2026
- Allergan Aesthetics Wins Health Canada Approval for Boey — Rapid-Onset Neuromodulator Clears Regulatory Hurdle Jun 26, 2026
- RHA Dynamic Volume Wins FDA Clearance for Midface Augmentation — New Rheology Profile Enters Market Jun 26, 2026
- Biostimulator Supremacy: Why Sculptra-Class Products Are Eating Filler's Lunch Jun 26, 2026
- Manufacturer Contract Season: How to Negotiate Volume Tiers Before You Re-Sign Jun 23, 2026
- Building a Tox-and-Filler Loyalty Stack: Layering Allē, Aspire, and Evolus Rewards Without Cannibalizing Margin Jun 22, 2026
- Anticipating the Next Injectable Price Increase: The Signals That Precede a List-Price Hike Jun 19, 2026
- Hyaluronidase Protocols: Stocking, Dosing, and the Vascular-Occlusion Emergency Kit Every Room Needs Jun 18, 2026
- Filler Rheology for Owners: G-Prime, Cohesivity, and Why It Dictates Which Product for Which Plane Jun 16, 2026
- Switching Your Tox: The Operational Playbook for Inventory, Retraining, Patient Comms, and the Rebate Reset Jun 14, 2026
- Cannula vs Needle Economics and Liability: When the Safer Technique Is Also the Better Margin Jun 13, 2026
- Managing Tox Resistance and Neutralizing Antibodies: Counseling the Patient and Switching Formulations Jun 12, 2026
- The Real Cost-Per-Unit Breakdown: Botox vs Dysport vs Jeuveau vs Daxxify vs Letybo (Loaded, Not List) Jun 12, 2026
- Dysport-to-Botox Conversion Ratios in Practice: Pricing and Dosing When You Run Both Jun 11, 2026
- Kybella vs CoolSculpting for the Double Chin: Injectable vs Device for Submental Fat Jun 9, 2026
- Reconstitution & Dilution Economics: How Your Saline Volume Quietly Changes Your Cost-Per-Unit Jun 9, 2026
- How Long Does Botox Take to Work — and Why the Answer Is a Retention Tool Jun 8, 2026
- Overfill Math: Getting 22–25 Units Out of a '20-Unit' Vial Without Compromising Results Jun 8, 2026
- Jawline Definition: The Treatment Options and the Consult That Sells the Plan Jun 7, 2026
- PRF vs Filler for the Under-Eye: Two Approaches to a Delicate Area Jun 7, 2026
- Diffusion Profiles That Matter Chairside: Why Field-of-Effect Changes Your Injection Map by Product Jun 7, 2026
- Restylane vs RHA: How Owners Should Think About Two HA Filler Families Jun 7, 2026
- Radiesse vs Hyaluronic Acid Filler: Biostimulator-Type vs HA Volume Jun 6, 2026
- Treating Under-Eye Concerns: Matching the Approach to the Cause (an Owner's Overview) Jun 6, 2026
- Dysport vs Daxxify: Diffusion and Duration as the Two Axes That Matter Jun 6, 2026
- 'Baby Botox' vs Traditional Dosing: Subtlety as a Treatment Philosophy Jun 5, 2026
- How Long Does Dysport Last — and Using Onset and Duration to Set Expectations Jun 5, 2026
- Thread Lift vs Filler: Lift vs Volume, and Setting the Right Patient Expectation Jun 5, 2026
- Filler vs Fat Transfer: Injectable Volume vs a Surgical Approach Jun 3, 2026
- How Long Does Lip Filler Last — and How Owners Should Use That for Rebooking Cadence Jun 3, 2026
- Lip Flip vs Lip Filler: Two Different Treatments Patients Constantly Confuse Jun 2, 2026
- How Much Does Sculptra Cost — and How Owners Should Price the Biostimulator Series Jun 2, 2026
- Semaglutide vs Tirzepatide for Medspas: What Owners Need to Know About Offering Each Jun 2, 2026
- How Much Does Lip Filler Cost — and How Owners Should Frame Lip Pricing Jun 1, 2026
- Dysport vs Jeuveau: Two Neurotoxin Alternatives in Different Lanes Jun 1, 2026
- Botox vs Fillers: When Each Is the Right Tool (and Why Patients Confuse Them) Jun 1, 2026
- RF Microneedling Market Size and Growth Aug 1, 2026
- Can an RN Own a Medical Spa Aug 1, 2026
- Email and SMS That Aren't Spam: The Lifecycle Flows That Drive Repeat Visits Jun 27, 2026
- Reputation Management: Turning Reviews Into Your Strongest Acquisition Channel Jun 25, 2026
- Using the Meta Ad Library to See Exactly What Your Competitors Are Promoting Jun 22, 2026
- Meta and Google Ads for Aesthetics: CAC Benchmarks and the Creative That Converts Jun 17, 2026
- The Compliant Before/After: Posting Results Without Triggering Board or Platform Violations Jun 11, 2026
- Before/After Photography: Why Consistent, Quality Images Are a Business Asset Jun 6, 2026
- Optimizing Your Google Business Profile: The Single Most Important Local SEO Asset Jun 5, 2026
- Med Spa SEO: Ranking for '[Treatment] Near Me' in a Saturated Local Market Jun 4, 2026
- Instagram for Med Spas: Building Trust and Demand Without Burning the Channel Jun 2, 2026
- The Med Spa Website That Converts: Turning Traffic Into Booked Consults Jun 1, 2026
- The Rebooking System: How Top Practices Hit 70%+ Rebooking at Checkout Jun 26, 2026
- Reactivation Campaigns: Winning Back the Lapsed Patients Already in Your Database Jun 24, 2026
- Building Treatment Packages That Increase AOV Without Discounting Yourself to Death Jun 24, 2026
- Retail and Skincare Attach: Turning Medical-Grade Skincare Into Real Margin Jun 23, 2026
- The Consultation-to-Treatment Conversion Playbook: Scripts, Pricing Reveals, and Objection Handling Jun 23, 2026
- Pricing Psychology for Aesthetics: Anchoring, Per-Unit vs Per-Area, and the Premium Position Jun 19, 2026
- Cross-Sell Maps by Service: What to Recommend Next After Tox, After Filler, After a Laser Series Jun 18, 2026
- Bundling Injectables With Skincare: Building Higher-Value, Stickier Treatment Plans Jun 8, 2026
- Building a Signature Treatment: Differentiation Through a Branded, Owned Offering Jun 8, 2026
- Pricing Transparency: How Much to Show, and What It Signals Jun 6, 2026
- Knowing Your Patient Segments: Why Not All Patients Are Equally Valuable Jun 5, 2026
- Designing a Med Spa Referral Program That Actually Drives Referrals Jun 4, 2026
- Competitive Positioning: Choosing What You Are Instead of Competing on Everything Jun 4, 2026
- New-Patient Offers: Attracting First Visits Without Training a Discount Habit Jun 3, 2026
- Should You Charge a Consultation Fee? The Strategy Behind the Decision Jun 3, 2026
- Memberships vs Packages: Which Recurring-Revenue Model Fits Your Practice Jun 1, 2026
- The Second-Location Decision: The Financial and Operational Signals You're Actually Ready Jun 25, 2026
- The Pricing Power Audit: How to Raise Prices 10–15% and Keep Your Patients Jun 25, 2026
- The RN-Injector Comp Arms Race: Structuring Pay to Retain Without Destroying Margin Jun 23, 2026
- Patient Financing Done Right: Cherry, Wisetack, PatientFi, and the True Cost of 'Free' Financing Jun 23, 2026
- No-Show and Cancellation Economics: Deposit Policies That Cut Losses Without Killing Bookings Jun 20, 2026
- Inventory and Vial Shrinkage Control: Where Product (and Money) Actually Disappears Jun 20, 2026
- Reading Your Own P&L Like an Aesthetic CFO: The Benchmarks That Flag a Sick Practice Jun 20, 2026
- Chair and Room Utilization: The Single Metric That Predicts Whether You Should Expand Jun 17, 2026
- Cost-of-Goods Targets by Service Line: What Your Injectable, Laser, and Skincare COGS Should Be Jun 11, 2026
- Seasonal Demand in Aesthetics: Planning Inventory, Staffing, and Marketing Around the Calendar Jun 9, 2026
- Gift Cards and Pre-Paid Strategy: Cash Now, Liability Later, and How to Handle Both Jun 8, 2026
- Managing Your Manufacturer Reps: Getting Value Without Being Managed by Them Jun 8, 2026
- When to Add a New Service Line: The Discipline Behind a Bigger Menu Jun 7, 2026
- Staff Retention Beyond Injectors: Keeping the Team That Runs the Practice Jun 7, 2026
- Handling Refund and Walkout Requests: Policy, Judgment, and Protecting the Relationship Jun 7, 2026
- Cash-Flow Management for Med Spas: Why Profitable Practices Still Run Out of Money Jun 6, 2026
- Online Booking: Reducing the Friction Between Interest and Appointment Jun 5, 2026
- Injectable Inventory Management: Par Levels, Expiration, and Capital Efficiency Jun 5, 2026
- Provider Compensation Models: Hourly vs Commission vs Hybrid and How Each Warps Behavior Jun 5, 2026
- Handling the Unhappy Patient: Turning Complaints Into Retention (or at Least Avoiding Escalation) Jun 4, 2026
- Treatment Room and Practice Flow: Designing Space for Efficiency and Experience Jun 4, 2026
- Designing the Patient Experience: The Differentiator That Survives Price Competition Jun 3, 2026
- The Front Desk Is Your Highest-Leverage Hire: What to Train and Why It Pays Jun 3, 2026
- Treating the Needle-Anxious Patient: Comfort as a Conversion and Retention Tool Jun 2, 2026
- Financial Benchmarks by Stage: What 'Healthy' Looks Like as a Practice Grows Jun 2, 2026
- The Med Spa KPIs Worth Tracking: The Handful of Numbers That Actually Run the Business Jun 2, 2026
- Aftercare That Drives Results and Retention: The Underused Touchpoint Jun 1, 2026
- The Consolidation Wave: Reading the PE Roll-Up Cycle and What It Means If You Don't Sell Jun 22, 2026
- The Longevity Crossover: How Aesthetics Practices Are Becoming Wellness and Longevity Clinics Jun 18, 2026
- AI in the Treatment Room: Imaging, Consult Tools, and Outcome Prediction Worth Adopting Jun 15, 2026
- The Regenerative Aesthetics Wave: Exosomes, PRF, Polynucleotides, and What's Real vs Hype Jun 13, 2026
- The Men's Aesthetics Inflection: Sizing the Segment and the Services That Actually Convert Men Jun 10, 2026
- The Year in Medical Aesthetics: An Owner's State-of-the-Industry Recap Jun 9, 2026
- Injectable Pipeline Watch: How to Read What's Heading for FDA Decisions Before It Hits Your Market Jun 8, 2026
- Korean Aesthetics Coming West: Skin Boosters, 'K-Tox,' and What US Owners Should Prepare For Jun 5, 2026
- Polynucleotide and 'Salmon Sperm' Boosters: The Demand Curve and the US Regulatory Catch Jun 4, 2026
- What to Watch in Medical Aesthetics in 2026: The Shifts That Will Move Your Revenue Jun 4, 2026
- Building a Regulatory Watch: Tracking the Scope-of-Practice and FDA Activity That Affects You Jun 3, 2026
- At-Home and Hybrid Devices: Threat to Your Treatments or Funnel Into Them? Jun 2, 2026
- Your First 90 Days Open: The Launch Checklist That Fills the Schedule Jun 20, 2026
- Hiring Your First Injector: Credentialing, Comp, and the Supervision Setup Jun 15, 2026
- Choosing Your Legal Structure: PC vs LLC vs MSO and the Ownership Rules by State Jun 14, 2026
- The Med Spa Business Plan That Gets Funded: Pro Formas, Assumptions, and Lender Expectations Jun 9, 2026
- Med Spa vs Day Spa: The Distinction That Shapes Everything From Services to Compliance Jun 6, 2026
- The Medical Director Agreement: What to Pay, What to Require, and What to Put in Writing Jun 5, 2026
- Evaluating Injector Training: What Separates Genuine Competency From a Weekend Certificate Jun 3, 2026
- How to Open a Med Spa: The Complete Regulatory, Financial, and Operational Roadmap Jun 3, 2026